Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Hauck EW, Weidner W. Francois de la Peyronie and the disease named after him. Lancet. 2001;357:2049–51.
2. Paulis G, Paulis A, Romano G, Barletta D, Fabiani A. Rationale of combination therapy with antioxidants in medical management of Peyronie’s disease: results of clinical application. Res Rep Urol. 2017;9:129–39.
3. Paulis G, Romano G, Paulis L, Barletta D. Recent pathophysiological aspects of Peyronie’s disease: role of free radicals, rationale, and therapeutic implications for antioxidant treatment-literature review. Adv Urol. 2017;2017:4653512.
4. Moreland RB, Nehra A. Pathophysiology of Peyronie’s disease. Int J Impot Res. 2002;14:406–10.
5. Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of Peyronie’s disease in the United States: a population-based study. PLoS ONE. 2016;11:e0150157.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献